Oral Abstract Session 01 - Global HIV Vaccine Enterprise

Recommendations

Info

CONFERENCE ORGANIZERS Conference Organizers Review Committee (cont.) Josephine Cox International AIDS Vaccine Initiative, USA Daniel Douek National Institutes of Health, USA Keith Fowke University of Manitoba, Canada Jonathan Fuchs San Francisco Department of Public Health, USA Paul Goepfert Department of Medicine, University of Alabama at Birmingham, USA Barney Graham Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA Tomas Hanke University of Oxford, UK Alexandre Harari Centre Hospitalier Universitaire Vaudois, Lausanne University Hospital, Switzerland Shiu-Lok Hu University of Washington, USA Eric Hunter Emory University, USA Stephen Kent University of Melbourne, Australia Roger Le Grand CEA, France David Margolis University of North Carolina at Chapel Hill, USA Margaret Juliana McElrath Fred Hutchinson Cancer Research Center, USA James McIntyre Anova Health Institute, South Africa Andrew McMichael University of Oxford, UK Nelson Michael U.S. Military HIV Research Program, USA Chris Milller University of California Davis, USA David Montefiori Duke University Medical Center, USA Lynn Morris National Institute for Communicable Diseases, South Africa Gary Nabel Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA Conference Secretariat Global HIV Vaccine Enterprise, USA Conference Solutions, USA Meeting Planner iv AIDS Vaccine 2012 Jo-Ann Passmore University of Cape Town, South Africa Harriet Robinson GeoVax, Inc., USA Nina Russell Bill & Melinda Gates Foundation, USA Eric Sandström Karolinska Institutet, Sweden Gabriella Scarlatti San Raffaele Scientific Institute, Italy Alexandra Schuetz U.S. Army Medical Component of the Armed Forces Research Institute of Medical Sciences, USA Olivier Schwartz Institut Pasteur, France Robin Shattock Imperial College, London, UK Guido Silvestri Emory University and Yerkes National Primate Research Center, USA Ronald Swanstrom University of North Carolina at Chapel Hill, USA Jim Tartaglia Sanofi Pasteur, USA Amalio Telenti Centre Hospitalier Universitaire Vaudois, Lausanne University Hospital, Switzerland Caroline Tanya Tiemessen National Institute for Communicable Diseases, South Africa Georgia Tomaras Duke Human Vaccine Institute, Duke University, USA Alexandra Trkola Institute of Medical Virology, University of Zurich, Switzerland Yegor Voronin Global HIV Vaccine Enterprise, USA Anna-Lise Williamson University of Cape Town, South Africa Susan Zolla-Pazner New York University School of Medicine, USA Michael Zwick The Scripps Research Institute, USA
New Investigator Awardees AIDS Vaccine 2012 is proud to introduce this year’s New Investigator Awardees. Ann Carias Northwestern University, USA Suefen Kwa Emory University, USA Roman Ntale University of Cape Town, South Africa Conference Scholars Adedayo Adeyemi MEASURE, Nigeria Fatima Ahmed Simon Fraser University, Canada Tina Ahmed University of Oxford, UK Joshua Amos Duke Human Vaccine Institute, Duke University, USA Raiees Andrabi All India Institute of Medical Sciences, India Debby Basu Emory Vaccine Center, USA Roger Bayingana Projet San Francisco, Rwanda Dion Benetatos Desmond Tutu HIV Foundation, South Africa Marina Biedma UMR 748, France Austin Boesch Thayer School of Engineering at Dartmouth College, USA Eric Brown Dartmouth College, USA Irene Bukh University of Pennsylvania, USA Madeleine Bunders Emma Children’s Hospital, Academic Medical Centre, University of Amsterdam, Netherlands Supranee Buranapraditkun Chulalongkorn University, Thailand Gabriela Calazans Centro de Referência e Treinamento DST/AIDS, Brazil Jorge Carrillo IrsiCaixa AIDS Research Institute–HIVACAT, Spain Antoine Chaillon Bretonneau University Hospital, France Bimal Chakrabarti International AIDS Vaccine Initiative at The Scripps Research Institute, USA Awards and Scholarships Jessica Prince Emory University, USA Damien Tully Ragon Institute of MGH, MIT and Harvard, USA Shivan Chetty University of Cape Town, South Africa Takayuki Chikata Center for AIDS Research, Kumamoto University, Japan Tumena Corrah Addenbrookes Hospital, University of Cambridge, UK Fernanda Côrtes Oswaldo Cruz Institute/FIOCRUZ, Brazil Laura Cotton Simon Fraser University, Canada Smritee Dabee University of Cape Town, South Africa Gabriel Damilano Argentinean National Reference Center for AIDS, Argentina Shao Elichilia Kilimanjaro Christian Medical Center, Tanzania Rene Ghislain Essomba International Centre for Genetic Engineering and Biotechnology, South Africa Zelda Euler Academic Medical Center, University of Amsterdam, Netherlands Olubunmi Fakunle University College Hospital Ibadan, Nigeria Andrew Ferguson University of Illinois at Urbana-Champaign, USA Genevieve Fouda Duke Human Vaccine Institute, Duke University, USA Guofen Gao The Catholic University of America, USA Andrew Gartland Fred Hutchinson Cancer Research Center, USA Tricia Gearhart University of Pittsburgh, USA Kamini Gounder HIV Pathogenesis Programme, Doris Duke Medical Research Institute, University of KwaZulu-Natal, South Africa Sebastian Grimm Dartmouth College, USA AIDS Vaccine 2012 v SCHOLARSHIP RECIPIENTS
Page 2 and 3: AIDS Vaccine 2012 PROGRAM AT A GLAN
Page 4 and 5: AIDS Vaccine 2012 Partners www.alli
Page 6 and 7: CONFERENCE ORGANIZERS Conference Or
Page 10 and 11: SCHOLARSHIP RECIPIENTS Awards and S
Page 12 and 13: SCHOLARSHIP RECIPIENTS Awards and S
Page 14 and 15: PROGRAM / MONDAY 2 Program Monday,
Page 16 and 17: PROGRAM / MONDAY 4 Program 11:00 -
Page 22 and 23: PROGRAM / TUESDAY 10 Program Tuesda
Page 24 and 25: PROGRAM / TUESDAY 12 Program 11:45
Page 26 and 27: PROGRAM / TUESDAY 14 Program 13:30
Page 28 and 29: PROGRAM / TUESDAY 16 Program Poster
Page 30 and 31: PROGRAM / TUESDAY 18 Program AIDS V
Page 32 and 33: PROGRAM / WEDNESDAY 20 Program Wedn
Page 34 and 35: 22 AIDS Vaccine 2012
Page 36 and 37: PLENARY SESSIONS 24 Plenary Session
Page 42 and 43: SYMPOSIA SESSIONS 30 Symposia Sessi
Page 58 and 59:
SYMPOSIA SESSIONS 46 Symposia Sessi
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
ORAL ABSTRACT SESSIONS 54 Oral Abst
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
92 AIDS Vaccine 2012
Page 106 and 107:
POSTERS 94 AIDS Vaccine 2012
Page 108 and 109:
POSTERS 96 Posters Topic 1: Adjuvan
Page 110 and 111:
POSTERS 98 Posters Topic 1: Adjuvan
Page 112 and 113:
POSTERS Posters Topic 1: Adjuvants,
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
POSTERS Posters Topic 2: Animal Mod
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
POSTERS Posters Topic 3: B Cell Imm
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Page 146 and 147:
Page 148 and 149:
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
Page 156 and 157:
Page 158 and 159:
Page 160 and 161:
Page 162 and 163:
POSTERS Posters Topic 4: Clinical V
Page 164 and 165:
Page 166 and 167:
Page 168 and 169:
Page 170 and 171:
Page 172 and 173:
Page 174 and 175:
Page 176 and 177:
POSTERS Posters Topic 5: HIV Transm
Page 178 and 179:
Page 180 and 181:
Page 182 and 183:
Page 184 and 185:
Page 186 and 187:
Page 188 and 189:
Page 190 and 191:
POSTERS Posters Topic 6: Immunogene
Page 192 and 193:
POSTERS Posters Topic 7: Innate Imm
Page 194 and 195:
Page 196 and 197:
Page 198 and 199:
Page 200 and 201:
Page 202 and 203:
POSTERS Posters Topic 8: Mucosal Im
Page 204 and 205:
Page 206 and 207:
Page 208 and 209:
Page 210 and 211:
Page 212 and 213:
POSTERS Posters Topic 9: Non-Vaccin
Page 214 and 215:
Page 216 and 217:
Page 218 and 219:
Page 220 and 221:
Page 222 and 223:
POSTERS Posters Topic 10: Social/Et
Page 224 and 225:
Page 226 and 227:
Page 228 and 229:
Page 230 and 231:
POSTERS Posters Topic 11: T Cell Im
Page 232 and 233:
Page 234 and 235:
Page 236 and 237:
Page 238 and 239:
Page 240 and 241:
Page 242 and 243:
Page 244 and 245:
Page 246 and 247:
Page 248 and 249:
Page 250 and 251:
Page 252 and 253:
Page 254 and 255:
POSTERS Posters Topic 12: Vaccine C
Page 256 and 257:
Page 258 and 259:
Page 260 and 261:
Page 262 and 263:
Page 264 and 265:
Page 266 and 267:
Page 268 and 269:
Page 270 and 271:
Page 272 and 273:
Page 274 and 275:
Page 276 and 277:
Page 278 and 279:
Page 280 and 281:
Page 282 and 283:
Page 284 and 285:
Page 286 and 287:
Page 288 and 289:
POSTERS Posters Topic 13: Pediatric
Page 290 and 291:
AUTHOR INDEX Author Index Brander,
Page 292 and 293:
AUTHOR INDEX Author Index Guan, Y .
Page 294 and 295:
AUTHOR INDEX Author Index Lucas, J.
Page 296 and 297:
AUTHOR INDEX Author Index Quinn, T
Page 298 and 299:
AUTHOR INDEX Author Index Wendel-Ha
Page 300 and 301:
Notes 288
Page 302 and 303:
Notes 290
Page 305:
Poster Session 1 - Monday, 10 Septe
show all

Oral Abstract Session 01 - Global HIV Vaccine Enterprise

Create successful ePaper yourself

Delete template?

Save as template?